Subscribe to this column
Clifford A. Hudis, MD, FACP, FASCO
Clifford A. Hudis, MD, FACP, FASCO, is the CEO of ASCO. Prior to this role, he served as Chief of the Breast Medicine Service and an attending physician at Memorial Sloan Kettering Cancer Center and as a professor in the Department of Medicine at Weill Cornell Medical College. He is a Past President of ASCO. His research interests include all areas of care related to breast cancer, with a focus on the development of novel systemic therapies and prevention interventions related to the obesity and inflammation. Follow Dr. Hudis on Twitter @CliffordHudis.
May 24, 2018
While more biosimilars will likely be available in oncology in the next several years, their specific impact on patient care is going to depend on patient and provider acceptance of these agents.
May 17, 2018
ASCO would like to inform you of some changes to MOC that are a direct result of your input and our open, transparent collaboration with the ABIM.
May 08, 2018
We examine how state-level health care policy may impact the care that we deliver to our patients with cancer, and why it's important for us to pay attention to and help shape bills and regulations moving in states.
Apr 06, 2018
Our vice president of Clinical Affairs breaks down the reporting changes you need to understand and address to avoid potential financial penalties in 2020.
Mar 30, 2018
The decisions the Board made will enable ASCO to define the behaviors and resources that support our professional community to achieve greater career satisfaction while delivering ever better care.
Mar 27, 2018
ASCO's current president explains why he's passionate about precision medicine, as well as the concerns that keep him up at night.
Latest Blogs